ENT Cancer: Clinical Trials

3 trials for ENT Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting. 1 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable1Not yet recruiting 1
Phase 31Completed 1

Follow ENT Cancer: new trials by email Literature Review of ENT Cancer trials Research Report on ENT Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Benefits of Early Collaboration Between Oncologists and Palliative Care Physicians in Cases of Unplanned Hospitalization for Patients With Metastatic Cancer
Early integrated palliative care, Usual oncological care - Cancer, Sarcoma Metastatic
Not applicableNot yet recruitingCentre Oscar Lambret4932026-10-012026-09-17
Prospective Study to Evaluate the Blood Kinetics of Immune Cells and Immunosuppressive Cytokines After Exposure to an Immunity Checkpoint Inhibitor (ICI): Study of the Impact of Chemotherapy
Blood samples - Non Small Cell Lung Cancer, Bladder Cancer
CompletedUniversity Hospital, Tours312021-09-032023-04-06
Randomized, Double Blind, Efficacy Study of Escitalopram in ENT Cancer Patients Suffering From Emotional Distress
Escitalopram, Placebo - ENT Cancer
Phase 3CompletedGustave Roussy, Cancer Campus, Grand Paris382009-04-012016-06-10

Narrower conditions

Carcinoma, Non-Small-Cell Lung (1)  ·  Gastrointestinal Neoplasms (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)  ·  Urinary Bladder Neoplasms (1)

Broader conditions

Neoplasms by Site (2)  ·  Bronchial Neoplasms (1)  ·  Carcinoma, Bronchogenic (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Gastrointestinal Diseases (1)  ·  Lung Diseases (1)  ·  Lung Neoplasms (1)  ·  Male Urogenital Diseases (1)  ·  Neoplasms (1)  ·  Neoplastic Processes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Blood Specimen Collection (1)  ·  Escitalopram (1)

Sponsors

Centre Oscar Lambret (1)  ·  Gustave Roussy, Cancer Campus, Grand Paris (1)  ·  University Hospital, Tours (1)

Countries

France (3)

Results publications

PMID 36999619

NIH funding

2008 (1)